Resolving Inflammation: Synthesis, Configurational Assignment, and Biological Evaluations of RvD1n-3 DPA.

New drugs that can resolve inflammation without immunosuppressive effects are at the medicinal chemistry frontier. Pro-resolving endogenously formed small molecules, that is, the resolvins, are excellent candidates displaying such bioactions. The first total synthesis of the specialized pro-resolving mediator RvD1n-3 DPA has been achieved using the underutilized sp3 -sp3 Negishi cross coupling reaction and an alkyne hydrosilylation-protodesilylation protocol. Biological evaluations revealed that this novel mediator displays low nanomolar pro-resolving properties and potently activates the human DRV1/GPR32 receptor. As such, this endogenous natural product is a lead compound for the development of novel immunoresolvents.

[1]  M. Aursnes,et al.  Stereoselective synthesis of protectin D1: a potent anti-inflammatory and proresolving lipid mediator. , 2014, Organic & biomolecular chemistry.

[2]  C. Serhan,et al.  The Protectin PCTR1 Is Produced by Human M2 Macrophages and Enhances Resolution of Infectious Inflammation. , 2016, The American journal of pathology.

[3]  S. Gordon.  Phagocytosis: An Immunobiologic Process. , 2016, Immunity.

[4]  P. Knochel,et al.  Recent Developments in Negishi Cross-Coupling Reactions , 2016 .

[5]  C. Serhan,et al.  Resolvin D1 binds human phagocytes with evidence for proresolving receptors , 2010, Proceedings of the National Academy of Sciences.

[6]  M. Aursnes,et al.  Stereoselective synthesis of maresin 1 , 2015 .

[7]  P. Mukherjee,et al.  Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Serhan,et al.  Resolvins , 2002, The Journal of experimental medicine.

[9]  J. Uddin,et al.  Resolvin D1 and Its Aspirin-triggered 17R Epimer , 2007, Journal of Biological Chemistry.

[10]  Yan Lu,et al.  Anti-Inflammatory Actions of Neuroprotectin D1/Protectin D1 and Its Natural Stereoisomers: Assignments of Dihydroxy-Containing Docosatrienes1 , 2006, The Journal of Immunology.

[11]  C. Serhan,et al.  Novel n-3 Immunoresolvents: Structures and Actions , 2013, Scientific Reports.

[12]  C. Serhan,et al.  Synthesis of the 16S,17S-Epoxyprotectin Intermediate in the Biosynthesis of Protectins by Human Macrophages. , 2015, Journal of natural products.

[13]  T. Hansen,et al.  PDn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function , 2018, Cell chemical biology.

[14]  Thomas Schmidt,et al.  sp3-sp3 Coupling reactions in the synthesis of natural products and biologically active molecules. , 2014, Natural product reports.

[15]  Derek W. Gilroy,et al.  Resolution of inflammation: a new therapeutic frontier , 2016, Nature Reviews Drug Discovery.

[16]  J. Uddin.  Design and synthesis of novel anti -inflammatory lipid mediators and anticancer small molecules , 2008 .

[17]  David E. Gloriam,et al.  Trends in GPCR drug discovery: new agents, targets and indications , 2017, Nature Reviews Drug Discovery.

[18]  Ira Tabas,et al.  Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities , 2013, Science.

[19]  Charles N Serhan,et al.  Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. , 2018, Journal of Clinical Investigation.

[20]  C. Serhan,et al.  Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. , 2014, American journal of physiology. Cell physiology.

[21]  C. Serhan,et al.  Synthesis and Anti-inflammatory and Pro-resolving Activities of 22-OH-PD1, a Monohydroxylated Metabolite of Protectin D1 , 2014, Journal of natural products.

[22]  T. Hansen,et al.  Recent advances in the chemistry and biology of anti-inflammatory and specialized pro-resolving mediators biosynthesized from n-3 docosapentaenoic acid. , 2017, Bioorganic & medicinal chemistry letters.

[23]  C. Serhan,et al.  Total synthesis of the anti-inflammatory and pro-resolving lipid mediator MaR1n-3 DPA utilizing an sp(3) -sp(3) Negishi cross-coupling reaction. , 2014, Chemistry.

[24]  T. Hansen,et al.  Stereocontrolled synthesis and investigation of the biosynthetic transformations of 16(S),17(S)-epoxy-PDn-3 DPA. , 2017, Organic & biomolecular chemistry.

[25]  Charles N. Serhan,et al.  Infection Regulates Pro-Resolving Mediators that Lower Antibiotic Requirements , 2012, Nature.

[26]  C. Serhan,et al.  Synthesis of 13(R)-Hydroxy-7Z,10Z,13R,14E,16Z,19Z Docosapentaenoic Acid (13R-HDPA) and Its Biosynthetic Conversion to the 13-Series Resolvins , 2016, Journal of natural products.

[27]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[28]  C. Serhan,et al.  Resolvins and protectins in the termination program of acute inflammation. , 2007, Trends in immunology.

[29]  Charles N. Serhan,et al.  Resolvin E1 and protectin D1 activate inflammation-resolution programmes , 2007, Nature.

[30]  C. Serhan,et al.  Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. , 2017, Molecular aspects of medicine.

[31]  E. Negishi,et al.  A highly efficient and selective synthesis of lissoclinolide featuring hydrogen transfer hydrozirconation,trans-selective Pd-catalyzed cross coupling of alkenylzirconiums with 1,1-dibromoalkenes and Ag-catalyzed lactonization providing(Z)-γ-alkylidenebutenolides , 1999 .

[32]  D. Gilroy,et al.  Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. , 2014, Immunity.

[33]  C. Serhan.  Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  E. M. Ferreira,et al.  Platinum-catalyzed hydrosilylations of internal alkynes: harnessing substituent effects to achieve high regioselectivity. , 2012, Angewandte Chemie.

[35]  C. Serhan,et al.  Total Synthesis of the Lipid Mediator PD1n-3 DPA: Configurational Assignments and Anti-inflammatory and Pro-resolving Actions , 2014, Journal of natural products.

[36]  C. Serhan,et al.  Resolvins and protectins in inflammation resolution. , 2011, Chemical reviews.

[37]  C. Serhan,et al.  Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells , 2003, The Journal of Biological Chemistry.

[38]  C. Serhan,et al.  Resolvins , 2002, The Journal of Experimental Medicine.

[39]  J. Haeggström,et al.  The novel 13S,14S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  B. Spur,et al.  Total synthesis of Resolvin D1, a potent anti-inflammatory lipid mediator , 2012 .

[41]  M. Organ,et al.  The first Negishi cross-coupling reaction of two alkyl centers utilizing a Pd-N-heterocyclic carbene (NHC) catalyst. , 2005, Organic letters.

[42]  C. Serhan,et al.  The Docosatriene Protectin D1 Is Produced by TH2 Skewing and Promotes Human T Cell Apoptosis via Lipid Raft Clustering* , 2005, Journal of Biological Chemistry.

[43]  K. Takai,et al.  Simple and selective method for RCHO → (E)-RCH=CHX conversion by means of a CHX3-CrCl2 system , 1986 .

[44]  Ang Li,et al.  Total Synthesis of Rubriflordilactone B. , 2016, Angewandte Chemie.

[45]  C. Serhan,et al.  Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions , 2009, The Journal of experimental medicine.